These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2995924)

  • 1. Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin.
    Burke JF; Mogg AE
    Nucleic Acids Res; 1985 Sep; 13(17):6265-72. PubMed ID: 2995924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene selective suppression of nonsense termination using antisense agents.
    Kulyté A; Dryselius R; Karlsson J; Good L
    Biochim Biophys Acta; 2005 Sep; 1730(3):165-72. PubMed ID: 16135388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of nonsense mutations in Aspergillus nidulans.
    Martinelli SD; Roberts TJ
    Biosci Rep; 1983 Jan; 3(1):11-7. PubMed ID: 6340750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside suppression at UAG, UAA and UGA codons in Escherichia coli and human tissue culture cells.
    Martin R; Mogg AE; Heywood LA; Nitschke L; Burke JF
    Mol Gen Genet; 1989 Jun; 217(2-3):411-8. PubMed ID: 2475756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system.
    Manuvakhova M; Keeling K; Bedwell DM
    RNA; 2000 Jul; 6(7):1044-55. PubMed ID: 10917599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of UAG, UAA, and UGA nonsense mutations at a specific site in the Escherichia coli chloramphenicol acetyltransferase gene: use in measurement of amber, ochre, and opal suppression in mammalian cells.
    Capone JP; Sedivy JM; Sharp PA; RajBhandary UL
    Mol Cell Biol; 1986 Sep; 6(9):3059-67. PubMed ID: 3023959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a vector, pRSVcatamb38, for the rapid and sensitive assay of amber suppression in human and other mammalian cells.
    Burke JF; Mogg AE
    Nucleic Acids Res; 1985 Feb; 13(4):1317-26. PubMed ID: 2987821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside-mediated suppression of nonsense mutations in late infantile neuronal ceroid lipofuscinosis.
    Sleat DE; Sohar I; Gin RM; Lobel P
    Eur J Paediatr Neurol; 2001; 5 Suppl A():57-62. PubMed ID: 11589009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two nucleotide substitutions in the A-site of yeast 18S rRNA affect translation and differentiate the interaction of ribosomes with aminoglycoside antibiotics.
    Tselika S; Konstantinidis TC; Synetos D
    Biochimie; 2008 Jun; 90(6):908-17. PubMed ID: 18331849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
    Keeling KM; Bedwell DM
    J Mol Med (Berl); 2002 Jun; 80(6):367-76. PubMed ID: 12072912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An amber suppressor tRNA gene derived by site-specific mutagenesis: cloning and function in mammalian cells.
    Laski FA; Belagaje R; RajBhandary UL; Sharp PA
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5813-7. PubMed ID: 6310546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic action of genetic and phenotypic suppression of nonsense mutations in yeast Saccharomyces cerevisiae.
    Surguchov AP; Pospelova EM; Smirnov VN
    Mol Gen Genet; 1981; 183(1):197-8. PubMed ID: 7035819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
    Nudelman I; Rebibo-Sabbah A; Cherniavsky M; Belakhov V; Hainrichson M; Chen F; Schacht J; Pilch DS; Ben-Yosef T; Baasov T
    J Med Chem; 2009 May; 52(9):2836-45. PubMed ID: 19309154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of some aminoglycosides upon a drug dependent Escherichia coli strain.
    Gadó I; Dumbovich I
    Acta Microbiol Acad Sci Hung; 1975; 22(2):95-104. PubMed ID: 1092134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context effects on misreading and suppression at UAG codons in human cells.
    Phillips-Jones MK; Hill LS; Atkinson J; Martin R
    Mol Cell Biol; 1995 Dec; 15(12):6593-600. PubMed ID: 8524224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics.
    Brendel C; Klahold E; Gärtner J; Huppke P
    Pediatr Res; 2009 May; 65(5):520-3. PubMed ID: 19190538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal suppressors and antisuppressors in Podospora anserina: altered susceptibility to paromomycin and relationships between genetic and phenotypic suppression.
    Coppin-Raynal E
    Biochem Genet; 1981 Aug; 19(7-8):729-40. PubMed ID: 7295296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kasugamycin inhibition of nonsense suppression by thymine-requiring strains of Escherichia coli K12.
    Tiganos E; Herrington MB
    Can J Microbiol; 1993 Apr; 39(4):448-50. PubMed ID: 8500013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of mammalian cell lines containing multiple nonsense mutations and functional suppressor tRNA genes.
    Hudziak RM; Laski FA; RajBhandary UL; Sharp PA; Capecchi MR
    Cell; 1982 Nov; 31(1):137-46. PubMed ID: 6760983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside antibiotic treatment of human fibroblasts: intracellular accumulation, molecular changes and the loss of ribosomal accuracy.
    Buchanan JH; Stevens A; Sidhu J
    Eur J Cell Biol; 1987 Feb; 43(1):141-7. PubMed ID: 3569303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.